Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02470715 · ClinicalTrials.gov registry record
Identifying Molecular Drivers of Cancer
A clinical trial, sponsored by Avera McKennan Hospital & University Health Center.
- Completed
- Registry status
- 579
- Enrollment target
NCT02470715 is a clinical trial that has completed, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 579 participants.
The verdict
NCT02470715 has completed, sponsored by Avera McKennan Hospital & University Health Center.
- COMPLETED
- Registry status
- 579 participants
- Enrollment target
Study Summary
The primary aim of this study is to identify drivers of cancer by performing comprehensive genetic, proteomic, and metabolomic characterization of patient samples as a basis for understanding the underlying cause of disease.
Interventions
- GENETIC Molecular profile
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 579 participants |
| Start Date | 2014-04 |
| Est. Completion | 2018-05-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02470715
The ClinicalTrials.gov registry entry for NCT02470715 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 579 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avera McKennan Hospital & University Health Center, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Molecular profile is the first listed.
NCT02470715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02470715 about?
NCT02470715 is a clinical study titled "Identifying Molecular Drivers of Cancer". The primary aim of this study is to identify drivers of cancer by performing comprehensive genetic, proteomic, and metabolomic characterization of patient samples as a basis for understanding the underlying cause of disease.
What is the current status of trial NCT02470715?
This trial is currently completed. The enrollment target is 579 participants. The study started on 2014-04. Estimated completion is 2018-05-22.
What interventions are being tested in trial NCT02470715?
The interventions under investigation include: Molecular profile (GENETIC).
Who is sponsoring clinical trial NCT02470715?
This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.